| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Baumal Caroline | Chief Medical Officer | C/O APELLIS PHARMACEUTICALS, INC., 100 FIFTH AVENUE, 3RD FLOOR, WALTHAM | /s/ David Watson, attorney-in-fact for Caroline Baumal | 21 Jan 2026 | 0001961100 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | APLS | Common Stock | Sale | $37,250 | -1,882 | -2.1% | $19.79 | 89,324 | 20 Jan 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2026. |